Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Morphological and genetic classification of lung cancer: variation in practice and implications for tailored treatment.

Histopathology - 1 Aug 2015

Cane Paul, Linklater Karen M, Nicholson Andrew G, Peake Michael D, Gosney John

Abstract excerpt

AIMS: Tailored therapy of lung cancer requires high-quality pathology. Tumours must be subtyped accurately and material preserved for genetic analysis upon which treatment is increasingly based. There is a presumption that pathologists have risen to this challenge, but the nature and degree of va...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Carcinoma, Non-Small-Cell Lung
Share to ErbB Receptors
Share to EGFR gene

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Share to Immunohistochemistry

Share to Lung Neoplasms

Share to Mutation

Share to Precision Medicine

Source

Identifiers

PMID: 25545849
DOI: 10.1111/his.12638

Genes

EGFR

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 4 Sept 2026. Prepared record publication-25545849-2026-09-04.2. Manifest publication-graph-cohort-2026-09-04.2.

Source receipt: PubMed via Helena Literature Corpus, retrieved 4 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Morphological and genetic classification of lung cancer: variation in practice and implications for tailored treatment.PMID 25545849Read ↗

The morphological and molecular diagnosis of lung cancer.Semantic proximity Read ↗

Molecular histology of lung cancer: From targets to treatmentsSemantic proximity Read ↗

What's new in non-small cell lung cancer for pathologists: the importance of accurate subtyping, EGFR mutations and ALK rearrangements.Semantic proximity Read ↗

Establishing an EGFR mutation screening service for non-small cell lung cancer – Sample quality criteria and candidate histological predictorsSemantic proximity Read ↗

Heterogeneity in Lung Cancer.Semantic proximity Read ↗

EGFR, KRAS, BRAF and ALK gene alterations in lung adenocarcinomas: patient outcome, interplay with morphology and immunophenotype.Semantic proximity Read ↗

Suitability of thoracic cytology for new therapeutic paradigms in non-small cell lung carcinoma: high accuracy of tumor subtyping and feasibility of EGFR and KRAS molecular testing.Semantic proximity Read ↗

Molecular Epidemiology and Histopathological Classifications of Lung Cancer in Africa: A Scoping Review ProtocolSemantic proximity Read ↗

Correlation between molecular analysis, diagnosis according to the 2015 WHO classification of unresected lung tumours and TTF1 expression in small biopsies and cytology specimens from 344 non-small cell lung carcinoma patients.Semantic proximity Read ↗

[Criteria of the molecular pathology testing of lung cancer].Semantic proximity Read ↗

[Different histological subtypes of lung cancer, mutations and rearrangements].Semantic proximity Read ↗

Mutation status concordance between primary lesions and metastatic sites of advanced non-small-cell lung cancer and the impact of mutation testing methodologies: a literature review.Semantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.